NCT06596668View on ClinicalTrials.gov

Drug-Drug Interaction Study of Bomedemstat and Carbamazepine in Healthy Adult Participants (MK-3543-020)

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

October 2, 2024

Primary Completion Date

February 5, 2025

Study Completion Date

March 11, 2025

Conditions

Healthy

Interventions

DRUG

bomedemstat

Oral tablet

DRUG

carbamazepine

Oral extended-release capsule

Trial Locations (1)

85283

Celerion, Inc. ( Site 0001), Tempe

All Listed Sponsors

lead

Merck Sharp & Dohme LLC

INDUSTRY

NCT06596668 - Drug-Drug Interaction Study of Bomedemstat and Carbamazepine in Healthy Adult Participants (MK-3543-020) | Biotech Hunter | Biotech Hunter